naproxen has been researched along with thromboxanes in 13 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 3,202 | 149 | 199 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, WW; Butt, R; Howard-Lock, H; Kean, WF; Lock, CJ; Rischke, J | 1 |
| Dahl, H | 1 |
| Anderson, S; Baird, B; Brater, DC; Campbell, WB | 1 |
| Burch, RM; Halushka, PV; Wise, WC | 1 |
| Lefer, AM; Smith, EF | 1 |
| Cook, GA; Elliott, SL; Hawkey, CJ; McAlindon, ME; Yeomans, ND | 1 |
| Asfaha, S; McKnight, W; Muscará, MN; Wallace, JL | 1 |
| Branson, J; Ford, M; Kellett, N; Mair, S; Milosavljev, S; Rordorf, C; Scott, G | 1 |
| Gertz, BJ; Reicin, A; Sperling, RS; Weir, MR | 1 |
| Day, CA; Jacob, RF; Mason, RP; Walter, MF | 1 |
| Geisslinger, G; Graff, J; Harder, S; Klinkhardt, U; Nüsing, RM; Seyberth, H; Skarke, C; Watzer, B | 1 |
| Bliden, KP; Centofanti, R; Gurbel, PA; Jarvis, S; Tantry, US; Troullos, E; Venkataraman, P; Zhu, J | 1 |
| Hjemdahl, P; Stiller, CO | 1 |
3 review(s) available for naproxen and thromboxanes
| Article | Year |
|---|---|
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood Pressure; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Humans; Isoenzymes; Lactones; Membrane Proteins; Models, Animal; Naproxen; Osteoarthritis; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfones; Thrombosis; Thromboxanes | 2003 |
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids.
Topics: Atherosclerosis; Cell Membrane; Cyclooxygenase 2 Inhibitors; Humans; Lactones; Lipid Peroxidation; Lipoproteins, LDL; Naproxen; Prostaglandins I; Risk Factors; Sulfones; Thromboxanes | 2007 |
Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Fibrinolytic Agents; Humans; Ibuprofen; Lactones; Naproxen; Prostaglandins; Prostaglandins I; Sulfones; Thromboxanes | 2022 |
5 trial(s) available for naproxen and thromboxanes
| Article | Year |
|---|---|
Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Furosemide; Humans; Ibuprofen; Indenes; Kidney; Male; Naproxen; Prostaglandins; Random Allocation; Renin; Sulindac; Thromboxanes | 1985 |
Gastric microbleeding following single and repeated dosing with naproxen.
Topics: Adaptation, Physiological; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gastric Lavage; Gastrointestinal Hemorrhage; Humans; Male; Naproxen; Stomach Diseases; Thromboxanes | 1995 |
Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects.
Topics: Adolescent; Adult; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Organic Chemicals; Pilot Projects; Prostaglandin-Endoperoxide Synthases; Thromboxanes | 2003 |
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
Topics: Adult; Antigens, Neoplasm; Blood Platelets; Celecoxib; Cell Adhesion; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Fibrinogen; Humans; Lactones; Leukocytes; Male; Naproxen; P-Selectin; Phospholipases A; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Prostaglandins; Pyrazoles; Reference Values; Sulfonamides; Sulfones; Thrombin; Thrombomodulin; Thromboxanes; Time Factors | 2007 |
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Naproxen; Platelet Aggregation Inhibitors; Thromboxane B2; Thromboxanes | 2018 |
5 other study(ies) available for naproxen and thromboxanes
| Article | Year |
|---|---|
Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets.
Topics: Collagen; Female; Humans; In Vitro Techniques; Male; Naproxen; Platelet Aggregation; Platelet Aggregation Inhibitors; Stereoisomerism; Thromboxane A2; Thromboxanes | 1989 |
Naproxen (Naprosyn). Pharmacokinetics: therapeutical relevance and tolerance profile.
Topics: Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Kinetics; Metabolic Clearance Rate; Migraine Disorders; Naproxen; Prostaglandins; Thromboxanes | 1986 |
Prostaglandin-independent inhibition of calcium transport by nonsteroidal anti-inflammatory drugs: differential effects of carboxylic acids and piroxicam.
Topics: Animals; Anti-Inflammatory Agents; Biological Transport, Active; Calcium; Carboxylic Acids; Cell Membrane; Cricetinae; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Indomethacin; Ion Channels; Meclofenamic Acid; Microsomes, Liver; Mitochondria, Liver; Naproxen; Piroxicam; Prostaglandins; Rats; Thiazines; Thromboxanes | 1983 |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.
Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Cats; Cell Membrane; Coronary Disease; Creatine Kinase; Lysosomes; Male; Naproxen; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1981 |
Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Collagen; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Exudates and Transudates; Gastric Mucosa; Inflammation; Isoenzymes; Male; Membrane Proteins; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Thromboxanes; Wound Healing | 2000 |